{"id":7937,"date":"2023-03-21T14:41:12","date_gmt":"2023-03-21T21:41:12","guid":{"rendered":"https:\/\/acsr1.com\/?page_id=7937"},"modified":"2026-07-21T20:20:23","modified_gmt":"2026-07-22T03:20:23","slug":"tissue-microarrays","status":"publish","type":"page","link":"https:\/\/www.acsr1.com\/?page_id=7937","title":{"rendered":"Tissue Microarrays"},"content":{"rendered":"<div id=\"pl-7937\"  class=\"panel-layout\" ><div id=\"pg-7937-0\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-7937-0-0\"  class=\"panel-grid-cell panel-grid-cell-empty\" ><\/div><\/div><div id=\"pg-7937-1\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-7937-1-0\"  class=\"panel-grid-cell\" ><div id=\"panel-7937-1-0-0\" class=\"so-panel widget widget_sow-headline panel-first-child panel-last-child\" data-index=\"0\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-headline so-widget-sow-headline-default-6b466e3f55ed-7937\"\n\t\t\t\n\t\t><div class=\"sow-headline-container \">\n\t\t\t\t\t\t\t<h2 class=\"sow-headline\">\n\t\t\t\t\t\tTMAs\t\t\t\t\t\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"decoration\">\n\t\t\t\t\t\t<div class=\"decoration-inside\"><\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n<\/div><\/div><\/div><div id=\"pgc-7937-1-1\"  class=\"panel-grid-cell\" ><div id=\"panel-7937-1-1-0\" class=\"so-panel widget widget_ink-tabs panel-first-child panel-last-child\" data-index=\"1\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-ink-tabs so-widget-ink-tabs-tabs-e0cebefdf741-7937\"\n\t\t\t\n\t\t>\n<div class=\"iw-so-tabs iw-so-tabs-vertical iw-so-tabs-default\">\n\n\t<ul class=\"iw-so-tabs-nav\">\n\n\t\t\t\t\t<li class=\"iw-so-tab-title\" id=\"tab-1-1\">\n\t\t\t\t<a href=\"#tab-1-1-content\">\n\t\t\t\t\t\t\t\t\t\t<span class=\"iw-so-tab-text\">Tissue Microarrays (TMAs) Digital Library<\/span>\n\t\t\t\t<\/a>\n\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t<li class=\"iw-so-tab-title\" id=\"tab-1-2\">\n\t\t\t\t<a href=\"#tab-1-2-content\">\n\t\t\t\t\t\t\t\t\t\t<span class=\"iw-so-tab-text\">KS (HIV related) <\/span>\n\t\t\t\t<\/a>\n\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t<li class=\"iw-so-tab-title\" id=\"tab-1-3\">\n\t\t\t\t<a href=\"#tab-1-3-content\">\n\t\t\t\t\t\t\t\t\t\t<span class=\"iw-so-tab-text\">Lymphoma (HIV related) <\/span>\n\t\t\t\t<\/a>\n\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t<li class=\"iw-so-tab-title\" id=\"tab-1-4\">\n\t\t\t\t<a href=\"#tab-1-4-content\">\n\t\t\t\t\t\t\t\t\t\t<span class=\"iw-so-tab-text\">Lymphoma (HIV negative) <\/span>\n\t\t\t\t<\/a>\n\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t<li class=\"iw-so-tab-title\" id=\"tab-1-5\">\n\t\t\t\t<a href=\"#tab-1-5-content\">\n\t\t\t\t\t\t\t\t\t\t<span class=\"iw-so-tab-text\">Non-AIDS-defining Cancers (HIV related)  <\/span>\n\t\t\t\t<\/a>\n\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t<li class=\"iw-so-tab-title\" id=\"tab-1-6\">\n\t\t\t\t<a href=\"#tab-1-6-content\">\n\t\t\t\t\t\t\t\t\t\t<span class=\"iw-so-tab-text\">Melanoma (HIV related)<\/span>\n\t\t\t\t<\/a>\n\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t<li class=\"iw-so-tab-title\" id=\"tab-1-7\">\n\t\t\t\t<a href=\"#tab-1-7-content\">\n\t\t\t\t\t\t\t\t\t\t<span class=\"iw-so-tab-text\">Multsite Autopsies (HIV related NHL) <\/span>\n\t\t\t\t<\/a>\n\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t<li class=\"iw-so-tab-title\" id=\"tab-1-8\">\n\t\t\t\t<a href=\"#tab-1-8-content\">\n\t\t\t\t\t\t\t\t\t\t<span class=\"iw-so-tab-text\">Multsite Autopsies (HIV related KS) <\/span>\n\t\t\t\t<\/a>\n\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t<li class=\"iw-so-tab-title\" id=\"tab-1-9\">\n\t\t\t\t<a href=\"#tab-1-9-content\">\n\t\t\t\t\t\t\t\t\t\t<span class=\"iw-so-tab-text\">Multisite Autopsies (HIV related Lung Cancer)<\/span>\n\t\t\t\t<\/a>\n\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t<li class=\"iw-so-tab-title\" id=\"tab-1-10\">\n\t\t\t\t<a href=\"#tab-1-10-content\">\n\t\t\t\t\t\t\t\t\t\t<span class=\"iw-so-tab-text\">Antiretrovirals in Kaposi Sarcoma (KS-ARKS)<\/span>\n\t\t\t\t<\/a>\n\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\n\t<\/ul>\n\n\t<div class=\"iw-so-tabs-content\">\n\n\t\t\t\t\t<div class=\"iw-so-tabs-panel\" id=\"tab-1-1-content\">\n\t\t\t\t<p><span style=\"color: #333333; font-weight: 500; background: #FFFFFF;\"><img class=\"size-medium wp-image-7615 alignleft\" src=\"https:\/\/acsr1.com\/wp-content\/uploads\/2023\/02\/tool-edited-2-300x300.jpg\" alt=\"\" width=\"300\" height=\"300\" \/><\/span><\/p>\n<p class=\"has-medium-font-size\"><span style=\"color: #7777777; font-weight: 500;\"><span style=\"color: #000000;\">Investigators requesting access to view Tissue Microarray (TMA) images are required to complete the<\/span>\u00a0<a title=\"Digital Library Access Form\" href=\"http:\/\/www.acsr1.com\/contact\/image-access-form\/\" target=\"_blank\" rel=\"noopener\"><strong>ACSR\u2019s Virtual Biorepository Access Agreement<\/strong><\/a>. \u00a0<span style=\"color: #000000;\">High level groupings of TMAs are listed in the menu to the left which link to a brief description of the individual TMA images available for viewing online. <\/span><\/span><\/p>\n<p class=\"has-medium-font-size\"><span style=\"font-weight: 500; color: #000000;\">Tissue Microarray (TMA) sections are distributed with an accompanying diagram. \u00a0The TMA diagram will show the relative placement of the patient tumor and orientation\/control cores. The investigator will also receive a Quality Assessment summary for the materials received. \u00a0This QA document will contain a pathologist\u2019s review of the H&amp;E for presence of core tissue and presence of tumor, as well as documentation of biological stains done to assess the tumor and nucleic acid integrity of each core. This QA may or may not have been done on a section near or adjacent to the sections you have received for your research. The percent of cores present is dependent upon the section number, the type of tissue and the method used to construct the TMA, therefore the total number of cores listed is an approximation based on the original number of cores embedded.<\/span><\/p>\n\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"iw-so-tabs-panel\" id=\"tab-1-2-content\">\n\t\t\t\t<p class=\"has-medium-font-size\"><span style=\"color: #7777777; font-weight: 500;\"><span style=\"color: #000000;\">KS (HIV related) oral, visceral and skin from the U.S. and sub-Saharan Africa (SSA). \u00a0Examples of TMA images are provided in the \"Image\" links below.<\/span><strong><span style=\"color: #000000;\"> Please go to our<\/span> <a href=\"http:\/\/www.acsr1.com\/contact\/image-access-form\/\" target=\"_blank\" rel=\"noopener noreferrer\">ACSR Digital Library<\/a>\u00a0<span style=\"color: #000000;\">for the complete collection of TMA images<\/span><\/strong><\/span><span style=\"font-weight: 500; color: #000000;\"><strong>.<\/strong><\/span><\/p>\n&nbsp;\n<p class=\"has-medium-font-size\"><strong><img class=\"size-thumbnail wp-image-7137 alignright\" src=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/SSA-KS-TMA-4-2010-HE-stain-150x150.png\" alt=\"\" width=\"150\" height=\"150\" \/><\/strong><\/p>\n\n<ul>\n \t<li><span style=\"color: #777777; font-weight: 500;\"><strong><span style=\"font-weight: 500;\"><span style=\"color: #000000;\">KS TMA #11 Oral 2015: Approx. 19 tumor cores from 19 cases (Limited availability; please inquire)<\/span>\u00a0 <\/span><\/strong><strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/KS-Oral-TMA-11-2015-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a>\u00a0<\/strong><\/span><\/li>\n \t<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">KS TMA #12 Oral 2015: Approx. 19 tumor cores from 19 cases <strong><span style=\"font-weight: 500;\">(Digital images only; TMA not available)<\/span><\/strong>\u00a0<\/span> <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/KS-Oral-TMA-12-2015-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a><\/strong><\/span><\/li>\n \t<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">KS TMA #13 Visceral 2015: Approx. 28 tumor cores from 28 cases<\/span> \u00a0<a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/KS-Visceral-TMA-13-2015-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Image<\/strong><\/a>\u00a0<\/span><\/li>\n \t<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">KS TMA #14 Visceral 2015: Approx. 28 tumor cores from 28 cases<\/span>\u00a0 <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/KS-Visceral-TMA-14-2015-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a><\/strong> <\/span><\/li>\n \t<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">KS TMA #15 Skin 2015: Approx. 28 tumor cores from 28 cases <strong><span style=\"font-weight: 500;\">(Limited availability; please inquire)<\/span><\/strong>\u00a0<\/span> <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/KS-Skin-TMA-15-2015-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a>\u00a0<\/strong><\/span><\/li>\n \t<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">KS TMA #16 Skin 2015: Approx. 28 tumor cores from 28 cases <strong><span style=\"font-weight: 500;\">(Digital images only; TMA not available)<\/span><\/strong><\/span>\u00a0 <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/KS-Skin-TMA-16-2015-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a><\/strong><\/span><\/li>\n \t<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">SSA KS TMA #3 2010: Approx. 44 tumor cores from 28 cases<\/span>\u00a0 <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/SSA-KS-TMA-3-2010-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a><\/strong><\/span><\/li>\n \t<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">SSA KS TMA #4 2010: Approx. 38 tumor cores from 23 cases<\/span>\u00a0 <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/SSA-KS-TMA-4-2010-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a>\u00a0<\/strong><\/span><\/li>\n \t<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">SSA KS TMA #5 2010: Approx. 36 tumor cores from 24 cases<\/span>\u00a0 <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/SSA-KS-TMA-5-2010-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a><\/strong><\/span><\/li>\n \t<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">SSA KS TMA #17 Oral 2016: Approx. 9 tumor cores from 9 cases<\/span> \u00a0<strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/SSA-KS-Oral-TMA-17-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a>\u00a0<\/strong><\/span><\/li>\n \t<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">SSA KS TMA #18 Visceral 2016: Approx. 9 tumor cores from 5 cases<\/span> \u00a0<strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/SSA-KS-Visceral-TMA-18-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a><\/strong>\u00a0<\/span><\/li>\n \t<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">SSA KS TMA #19-1 Skin 2016: Approx. 28 tumor cores from 28 cases<\/span> \u00a0<a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/SSA-KS-Skin-TMA-19_1-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Image<\/strong><\/a>\u00a0<\/span><\/li>\n \t<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">SSA KS TMA #19-2 Skin 2016: Approx. 27 tumor cores from 27 cases<\/span> <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/SSA-KS-Skin-TMA-19_2-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a><\/strong>\u00a0<\/span><\/li>\n \t<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">SSA KS TMA #19-3 Skin 2016: Approx. 9 tumor cores from 9 cases<\/span> \u00a0<strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/SSA-KS-Skin-TMA-19_3-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a>\u00a0<\/strong><\/span><\/li>\n \t<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">SSA KS TMA #20 Skin 2016: Approx. 32 tumor cores from 32 cases <\/span>\u00a0<strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/SSA-KS-Skin-TMA-20-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a>\u00a0<\/strong><\/span><\/li>\n \t<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">SSA KS TMA #21 Visceral 2016: Approx. 8 tumor cores from 4 cases<\/span> \u00a0<strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/SSA-KS-Visceral-TMA-21-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a>\u00a0<\/strong><\/span><\/li>\n<\/ul>\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"iw-so-tabs-panel\" id=\"tab-1-3-content\">\n\t\t\t\t<p class=\"has-medium-font-size\"><span style=\"color: #7777777; font-weight: 500;\"><span style=\"color: #000000;\">Lymphoma (HIV related) from the U.S.\u00a0Examples of TMA images are provided in the \"Image\" links below.<\/span><strong><span style=\"color: #000000;\"> Please go to our<\/span> <a href=\"http:\/\/www.acsr1.com\/contact\/image-access-form\/\" target=\"_blank\" rel=\"noopener noreferrer\">ACSR Digital Library<\/a>\u00a0for the complete collection of TMA images.<\/strong><\/span><\/p>\n<ul>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">Misc. Lymphoma TMA 2010: Approx. 50 tumor cores from 31 cases<\/span> <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Misc.-Lymphoma-TMA-2010-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a>\u00a0<\/strong><\/span><\/li>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">DLBCL HIV+ TMA #4 2014: Approx. 10 tumor cores from 10 cases<\/span> <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/DLBCL-HIVpos-TMA-4-2014-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a><\/strong><\/span><\/li>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">DLBCL HIV+ TMA #5 2014: Approx. 10 tumor cores from 10 cases<\/span> <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/DLBCL-HIVpos-TMA-5-2014-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a>\u00a0<\/strong><\/span><\/li>\n<li><span style=\"color: #000000; font-weight: 500;\">DLBCL HIV+ TMA #8 2014: Approx. 54 tumor cores from 43 cases <\/span><span style=\"color: #777777; font-weight: 500;\"><strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/DLBCL-HIVpos-TMA-8-2015-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a><\/strong>\u00a0<\/span><\/li>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">DLBCL HIV+ TMA #9 2014: Approx. 54 tumor cores from 45 cases<\/span><strong>\u00a0<a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/DLBCL-HIVpos-TMA-9-2015-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a><\/strong>\u00a0<\/span><\/li>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">Burkitt Lymphoma TMA #1 2017: Approx. 40 tumor cores from 26 cases<\/span> <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/BL-TMA-1-2017-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a><\/strong><\/span><\/li>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">Burkitt Lymphoma TMA #2 2017: Approx. 29 tumor cores from 19 cases<\/span> <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/BL-TMA-2-2017-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a>\u00a0<\/strong><\/span><\/li>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">Burkitt Lymphoma TMA #3 Bone Marrow 2017: Approx. 8 tumor cores from 6 cases<\/span> <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/BL-TMA-3-2017-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a>\u00a0<\/strong><\/span><\/li>\n<\/ul>\n<p><span style=\"color: #777777; font-weight: 500;\"><strong>\u00a0<\/strong><\/span>\u00a0<img class=\"size-medium wp-image-7113 aligncenter\" src=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Misc.-Lymphoma-TMA-1-2014-HE-stain-300x158.png\" alt=\"\" width=\"300\" height=\"158\" \/><\/p>\n\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"iw-so-tabs-panel\" id=\"tab-1-4-content\">\n\t\t\t\t<p class=\"has-medium-font-size\"><span style=\"color: #7777777; font-weight: 500;\"><span style=\"color: #000000;\">Lymphoma (HIV negative) from the U.S.\u00a0Examples of TMA images are provided in the \"Image\" links below.<\/span><strong><span style=\"color: #000000;\"> Please go to our<\/span> <a href=\"http:\/\/www.acsr1.com\/contact\/image-access-form\/\" target=\"_blank\" rel=\"noopener noreferrer\">ACSR Digital Library<\/a><span style=\"color: #000000;\"> for the complete collection of TMA images.<\/span><\/strong><\/span><\/p>\n<p><img class=\"size-medium wp-image-3804 aligncenter\" src=\"https:\/\/acsr1.com\/wp-content\/uploads\/2017\/08\/Misc.Lymphoma-TMA-TA10-004-Ohio-2010-HE-300x181.jpg\" alt=\"\" width=\"300\" height=\"181\" \/><\/p>\n<ul>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">PTLD TMA #1 2013: Approx. 11 tumor cores from\u00a0 11 cases<\/span> <a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/PTLD-TMA-1-2013-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Image<\/strong><\/a><\/span><\/li>\n<li><span style=\"color: #000000;\">PTLD TMA #2 2013: Approx. 11 tumor cores from 11 cases<\/span> <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/PTLD-TMA-2-2013-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a><\/strong><\/li>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">Misc Lymphoma TMA #1 2014: Approx. 52 tumor cores from 26 cases<\/span> <a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Misc.-Lymphoma-TMA-1-2014-HE-stain.png\" target=\"_blank\" rel=\"noopener\"><strong>Image<\/strong><\/a>\u00a0<\/span><\/li>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">Misc lymphoma TMA #2 2014: Approx. 52 cores from 25 cases<\/span> <a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Misc.-Lymphoma-TMA-2-2014-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Image<\/strong><\/a> <\/span><\/li>\n<li><span style=\"color: #000000;\">DLBCL HIV negative TMA #6 2015: Approx. 38 cores from 38 cases<\/span> <strong>\u00a0<a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/DLBCL-HIVneg-TMA-6-2015-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a><\/strong><\/li>\n<li><span style=\"color: #000000;\">DLBCL HIV negative TMA #7 2015: Approx. 38 tumor cores from 38 cases<\/span> <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/DLBCL-HIVneg-TMA-7-2015-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a>\u00a0<\/strong><\/li>\n<\/ul>\n\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"iw-so-tabs-panel\" id=\"tab-1-5-content\">\n\t\t\t\t<p class=\"has-medium-font-size\"><span style=\"color: #7777777; font-weight: 500;\"><span style=\"color: #000000;\">Non-AIDS-defining Cancers (HIV related) from the U.S.\u00a0Examples of TMA images are provided in the \"Image\" links below.<\/span><strong><span style=\"color: #000000;\"> Please go to our<\/span> <a href=\"http:\/\/www.acsr1.com\/contact\/image-access-form\/\" target=\"_blank\" rel=\"noopener noreferrer\">ACSR Digital Library<\/a>\u00a0<span style=\"color: #000000;\">for the complete collection of TMA images.<\/span><\/strong><\/span><\/p>\n<p><strong>ANAL<\/strong><\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><span style=\"color: #000000;\">Anal Invasive TMA #1 2014: <span style=\"font-weight: 500;\">Approx. <\/span>12 tumor cores from 24 cases<\/span>\u00a0<a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Anal-Invasive-TMA-1-2014-Vimentin-stain.png\" target=\"_blank\" rel=\"noopener\" aria-describedby=\"audioeye_new_window_message\"><strong>Image<\/strong><\/a><\/li>\n<li><span style=\"color: #000000;\">Anal Invasive TMA #2 2014: <span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">Approx.<\/span> <\/span>10 tumor cores from 10 cases <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Anal-Invasive-TMA-2-2014-Vimentin-stain.png\" target=\"_blank\" rel=\"noopener\" aria-describedby=\"audioeye_new_window_message\">Image<\/a><\/strong><\/span><\/li>\n<li><span style=\"color: #000000;\">Anal In situ TMA #3 2014: <span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">Approx.<\/span> <\/span>19 tumor cores from 19 cases: Limited number of pre-cut slides available, unable to make new fresh cuts <a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Anal-InSitu-TMA-3-2014-Vimentin-stain.png\" target=\"_blank\" rel=\"noopener\" aria-describedby=\"audioeye_new_window_message\"><strong>Image\u00a0<\/strong><\/a><\/span><\/li>\n<li><span style=\"color: #000000;\">Anal In situ TMA #4 2014: <span style=\"color: #777777; font-weight: 500;\">Approx. <\/span>7 tumor cores from 7 cases: Limited number of pre-cut slides available, unable to make new fresh cuts\u00a0<strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Anal-InSitu-TMA-4-2014-Vimentin-stain.png\" target=\"_blank\" rel=\"noopener\">Image<\/a>\u00a0<\/strong><\/span><\/li>\n<li><span style=\"color: #000000;\">Anal Invasive TMA #1 2018: <span style=\"font-weight: 500;\">Approx. <\/span>16 tumor cores from 13 cases\u00a0<a title=\"Anal Invasive TMA 1 2018\" href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Anal-Invasive-TMA-1-2018-HE-stain.png\" target=\"_blank\" rel=\"noopener\" aria-describedby=\"audioeye_new_window_message\"><strong>Image<\/strong><\/a><\/span><\/li>\n<li><span style=\"color: #000000;\">Anal Invasive TMA #2 2018: <span style=\"font-weight: 500;\">Approx. <\/span>12 tumor cores from 10 cases <a title=\"Anal Invasive TMA 2 2018\" href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Anal-Invasive-TMA-2-2018-HE-stain.svs-.png\" target=\"_blank\" rel=\"noopener\" aria-describedby=\"audioeye_new_window_message\"><strong>Image<\/strong><\/a><\/span><\/li>\n<li><span style=\"color: #000000;\">Anal In Situ TMA #3 2018: <span style=\"font-weight: 500;\">Approx. <\/span>8 tumor cores from 7 cases: Limited number of pre-cut slides available, unable to make new fresh cuts <a title=\"Anal InSitu TMA 3 2018\" href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Anal-InSitu-TMA-3-2018-HE-stain.png\" target=\"_blank\" rel=\"noopener\" aria-describedby=\"audioeye_new_window_message\"><strong>Image<\/strong><\/a><\/span><\/li>\n<li><span style=\"color: #000000;\">Anal Brazilian TMA #1 2021: <span style=\"font-weight: 500;\">Approx. <\/span>14 tumor cores from 13 cases\u00a0<strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Anal-Brazilian-TMA-1-2021-HE-stain.png\" target=\"_blank\" rel=\"noopener\" aria-describedby=\"audioeye_new_window_message\">Image<\/a><\/strong><\/span><\/li>\n<li><span style=\"color: #000000;\">Anal Brazilian TMA 2 2021:<span style=\"font-weight: 500;\"> Approx. <\/span>14 tumor cores from 13 cases\u00a0<a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Anal-Brazilian-TMA-2-2021-HE-stain.png\" target=\"_blank\" rel=\"noopener\" aria-describedby=\"audioeye_new_window_message\"><strong>Image<\/strong><\/a><\/span><\/li>\n<li><span style=\"color: #000000;\">Anal Brazilian TMA 3 2021: <span style=\"font-weight: 500;\">Approx. <\/span>14 tumor cores from 14 cases\u00a0<a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Anal-Brazilian-TMA-3-2021-HE-stain.png\" target=\"_blank\" rel=\"noopener\" aria-describedby=\"audioeye_new_window_message\"><strong>Imag<\/strong><strong>e<\/strong><\/a><\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>BREAST<\/strong><\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><span style=\"color: #000000;\">Breast TMA #1 2017: <span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">Approx.<\/span> <\/span>10 tumor cores from 10 patients <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Breast-TMA-1-2017-HE-stain.png\" target=\"_blank\" rel=\"noopener\" aria-describedby=\"audioeye_new_window_message\">Image<\/a><\/strong><\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><strong>HEAD AND NECK<\/strong><\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><span style=\"color: #000000;\">Head and Neck TMA #1 2018: <span style=\"font-weight: 500;\">Approx. <\/span>27 tumor cores from 25 cases\u00a0<strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Head-Neck-TMA-1-2018-HE-stain.png\" target=\"_blank\" rel=\"noopener\" aria-describedby=\"audioeye_new_window_message\">Image<\/a>\u00a0<\/strong><\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><strong>HODGKIN'S DISEASE<\/strong><\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><span style=\"color: #000000;\">Hodgkin's Disease TMA #2 2011: <span style=\"font-weight: 500;\">Approx. <\/span>58 tumor cores from 26 cases\u00a0<strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/HD-TMA-2-2011-HE-stain.png\" target=\"_blank\" rel=\"noopener\" aria-describedby=\"audioeye_new_window_message\">Image<\/a>\u00a0<\/strong><\/span><\/li>\n<li><span style=\"color: #000000;\">Hodgkin's Disease TMA #4 2011: <span style=\"font-weight: 500;\">Approx. <\/span>58 tumor cores from 27 cases\u00a0<strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/HD-TMA-4-2011-HE-stain.png\" target=\"_blank\" rel=\"noopener\" aria-describedby=\"audioeye_new_window_message\">Image<\/a><\/strong><\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><strong>LUNG<\/strong><\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><span style=\"color: #000000;\">Lung Cancer TMA #1 2016: <span style=\"font-weight: 500;\">Approx. <\/span>16 tumor cores from 14 cases\u00a0<strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Lung-Cancer-TMA-1-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener\" aria-describedby=\"audioeye_new_window_message\">Image\u00a0<\/a><\/strong><\/span><\/li>\n<li><span style=\"color: #000000;\">Lung Cancer TMA #2 2016: <span style=\"font-weight: 500;\">Approx. <\/span>15 tumor cores from 13 cases\u00a0<strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Lung-Cancer-TMA-2-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener\" aria-describedby=\"audioeye_new_window_message\">Image<\/a>\u00a0<\/strong><\/span><\/li>\n<li><span style=\"color: #000000;\">Lung Cancer TMA #1 2020: <span style=\"font-weight: 500;\">Approx. <\/span>21 tumor cores from 20 cases\u00a0<a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Lung-TMA-1-2020-HE-stain.png\" target=\"_blank\" rel=\"noopener\" aria-describedby=\"audioeye_new_window_message\"><strong>Image<\/strong><\/a><\/span><\/li>\n<li><span style=\"color: #000000;\">Lung Cancer TMA #2 2020: <span style=\"font-weight: 500;\">Approx. <\/span>21 tumor cores from 20 cases\u00a0<a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Lung-TMA-2-2020-HE-stain.png\" target=\"_blank\" rel=\"noopener\" aria-describedby=\"audioeye_new_window_message\"><strong>Image<\/strong><\/a><\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><strong>PROSTATE<\/strong><\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><span style=\"color: #000000;\">Prostate Cancer TMA #1 2016: <span style=\"color: #777777; font-weight: 500;\">Approx. <\/span>9 tumor cores from 8 cases\u00a0<strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Prostate-Cancer-TMA-1-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener\" aria-describedby=\"audioeye_new_window_message\">Image<\/a><\/strong><\/span><\/li>\n<li><span style=\"color: #000000;\">Prostate Cancer TMA #2 2016: <span style=\"color: #777777; font-weight: 500;\">Approx. <\/span>9 tumor cores from 8 cases <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Prostate-Cancer-TMA-2-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener\" aria-describedby=\"audioeye_new_window_message\">Image<\/a>\u00a0<\/strong><\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><strong>PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)<\/strong><\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><span style=\"color: #000000;\">PCNSL TMA #1 2017: <span style=\"font-weight: 500;\">Approx. <\/span>37 tumor cores from 27 cases\u00a0<strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/PCNSL-TMA-1-2017-HE-stain.png\" target=\"_blank\" rel=\"noopener\" aria-describedby=\"audioeye_new_window_message\">Image<\/a>\u00a0<\/strong><\/span><\/li>\n<li><span style=\"color: #000000;\">PCNSL TMA #2 2017: <span style=\"font-weight: 500;\">Approx. <\/span>28 tumor cores from 20 cases\u00a0<strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/PCNSL-TMA-2-2017-HE-stain.png\" target=\"_blank\" rel=\"noopener\" aria-describedby=\"audioeye_new_window_message\">Image<\/a><\/strong><\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"iw-so-tabs-panel\" id=\"tab-1-6-content\">\n\t\t\t\t<p class=\"has-medium-font-size\"><span style=\"color: #7777777; font-weight: 500;\"><span style=\"color: #000000;\">Melanoma TMAs 1 &amp; 2 2023 from the U.S. contain different cores from 6 unique cases. Examples of TMA images are provided in the \"Image\" links below.<strong><span style=\"color: #000000;\"> Please go to our<\/span> <a href=\"http:\/\/www.acsr1.com\/contact\/image-access-form\/\" target=\"_blank\" rel=\"noopener noreferrer\">ACSR Digital Library<\/a>\u00a0<span style=\"color: #000000;\">for the complete collection of TMA images.<\/span><\/strong><\/span><\/span><\/p>\n<p>&nbsp;<\/p>\n<ul>\n<li>Melanoma TMA 1 2023: Approx. 18 skin tumor cores, 14 skin normal cores (14 tumors with 14 adjacent normal), 4 controls, 6 unique melanoma cases, 1 case with metastatic melanoma with serially collected lesions over time\u00a0<strong> <a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2026\/07\/Melanoma-TMA-1_2023.jpg\" target=\"_blank\" rel=\"noopener\">Image<\/a><\/strong><\/li>\n<li>Melanoma TMA 2 2023: Approx. 15 skin tumor cores, 17 skin normal cores (13 tumors with 13 adjacent normal), 4 controls, 5 unique melanoma cases, 1 case with metastatic melanoma with serially collected lesions over time\u00a0 <a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2026\/07\/Melanoma-TMA-2_2023.jpg\" target=\"_blank\" rel=\"noopener\"><strong>Image<\/strong><\/a><\/li>\n<\/ul>\n\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"iw-so-tabs-panel\" id=\"tab-1-7-content\">\n\t\t\t\t<p class=\"has-medium-font-size\"><span style=\"color: #7777777; font-weight: 500;\"><span style=\"color: #000000;\">Multisite Autopsies (HIV related non-Hodgkin lymphoma) includes involved and uninvolved tissues. Examples of TMA images are provided in the \"Image\" links below.<\/span><strong><span style=\"color: #000000;\"> Please go to our<\/span> <a href=\"http:\/\/www.acsr1.com\/contact\/image-access-form\/\" target=\"_blank\" rel=\"noopener noreferrer\">ACSR Digital Library<\/a>\u00a0<span style=\"color: #000000;\">for the complete collection of TMA images.<\/span><\/strong><\/span><\/p>\n<ul>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">NHL TMA #9 2016: Approx. 7 tumor cores and 18 benign cores from 1 case <strong><span style=\"font-weight: 500;\">(Limited availability; please inquire)<\/span><\/strong><\/span> <a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Autopsy-NHL-TMA-9-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Image<\/strong><\/a>\u00a0<\/span><\/li>\n<li><span style=\"color: #000000; font-weight: 500;\">NHL TMA #10 2016: Approx. 7 tumor cores and 18 benign cores from 1 case <span style=\"color: #777777; font-weight: 500;\"><strong><span style=\"font-weight: 500;\"><span style=\"color: #000000;\">(Limited availability; please inquire)<\/span><\/span><\/strong><\/span> <\/span><span style=\"color: #777777; font-weight: 500;\"><strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Autopsy-NHL-TMA-10-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a>\u00a0<\/strong><\/span><\/li>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">NHL TMA #11 2016: Approx. 16 tumor cores and 18 benign cores from 1 case <strong><span style=\"font-weight: 500;\">(Limited availability; please inquire)<\/span><\/strong><\/span><strong>\u00a0<a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Autopsy-NHL-TMA-11-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a><\/strong> <\/span><\/li>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">NHL TMA #12 2016: Approx. 12 tumor cores and 22 benign cores from 1 case <strong><span style=\"font-weight: 500;\">(Limited availability; please inquire)<\/span><\/strong><\/span> <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Autopsy-NHL-TMA-12-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a><\/strong><\/span><\/li>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">NHL TMA #13-1 2016: Approx. 20 tumor cores and 12 benign cores from 1 case <strong><span style=\"font-weight: 500;\">(Limited availability; please inquire)<\/span><\/strong><\/span> <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Autopsy-NHL-TMA-13_1-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a>\u00a0<\/strong><\/span><\/li>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">NHL TMA #13-2 2016: Approx. 4 tumor cores and 17 benign cores from 1 case <strong><span style=\"font-weight: 500;\">(Limited availability; please inquire)<\/span><\/strong><\/span> <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Autopsy-NHL-TMA-13_2-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a><\/strong>\u00a0<\/span><\/li>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">NHL TMA #14-1 2016: Approx. 18 tumor cores and 14 benign cores from 1 case <strong><span style=\"font-weight: 500;\">(Limited availability; please inquire)<\/span><\/strong><\/span> <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Autopsy-NHL-TMA-14_1-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a><\/strong>\u00a0<\/span><\/li>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">NHL TMA #14-2 2016: Approx. 4 tumor cores and 17 benign cores from 1 case <strong><span style=\"font-weight: 500;\">(Limited availability; please inquire)<\/span><\/strong><\/span> <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Autopsy-NHL-TMA-14_2-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a><\/strong><\/span><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><img class=\" wp-image-7103 aligncenter\" src=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Autopsy-NHL-TMA-12-2016-HE-stain-300x236.png\" alt=\"\" width=\"439\" height=\"345\" \/><\/p>\n\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"iw-so-tabs-panel\" id=\"tab-1-8-content\">\n\t\t\t\t<p class=\"has-medium-font-size\"><span style=\"color: #7777777; font-weight: 500;\"><span style=\"color: #000000;\">Multsite Autopsies (HIV related Kaposi Sarcoma) includes involved and uninvolved tissues.\u00a0Examples of TMA images are provided in the \"Image\" links below.<\/span><strong><span style=\"color: #000000;\"> Please go to our<\/span> <a href=\"http:\/\/www.acsr1.com\/contact\/image-access-form\/\" target=\"_blank\" rel=\"noopener noreferrer\">ACSR Digital Library<\/a>\u00a0<span style=\"color: #000000;\">for the complete collection of TMA images.<\/span><\/strong><\/span><\/p>\n<p>&nbsp;<\/p>\n<ul>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">KS TMA #1 2016: Approx. 4 tumor cores and 13 benign cores from 1 case <strong><span style=\"font-weight: 500;\">(Limited availability; please inquire)<\/span><\/strong><\/span> <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Autopsy-KS-TMA-1-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a>\u00a0<\/strong><\/span><\/li>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">KS TMA #2 2016: Approx. 3 tumor cores and 13 benign cores from 1 case <strong><span style=\"font-weight: 500;\">(Limited availability; please inquire)<\/span><\/strong><\/span> <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Autopsy-KS-TMA-2-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a><\/strong>\u00a0<\/span><\/li>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">KS TMA #3 2016: Approx. 4 tumor cores and 9 benign cores from 1 case <strong><span style=\"font-weight: 500;\">(Limited availability; please inquire)<\/span><\/strong><\/span> <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Autopsy-KS-TMA-3-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a><\/strong>\u00a0<\/span><\/li>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">KS TMA #4 2016: Approx. 8 tumor cores\u00a0 and 14 benign cores from 1 case <strong><span style=\"font-weight: 500;\">(Limited availability; please inquire)<\/span><\/strong><\/span> <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Autopsy-KS-TMA-4-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a><\/strong>\u00a0<\/span><\/li>\n<li><span style=\"color: #000000;\">KS TMA #5 2016: Approx. 4 tumor cores and 14 benign cores from 1 case <span style=\"color: #777777;\">(Limited availability; please inquire)<\/span><\/span>\u00a0<span style=\"color: #777777; font-weight: 500;\"><strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Autopsy-KS-TMA-5-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener noreferrer\">Image<\/a>\u00a0<\/strong><\/span><\/li>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">KS TMA #6 2016: Approx. 4 tumor cores and 14 benign cores from 1 case <strong><span style=\"font-weight: 500;\">(Limited availability; please inquire)<\/span><\/strong><\/span> <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Autopsy-KS-TMA-6-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener\">Image<\/a>\u00a0<\/strong><\/span><\/li>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">KS TMA #7 2016: Approx. 3 tumor cores and 17 benign cores from 1 case <strong><span style=\"font-weight: 500;\">(Limited availability; please inquire)<\/span><\/strong><\/span> <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Autopsy-KS-TMA-7-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener\">Image<\/a><\/strong> <\/span><\/li>\n<li><span style=\"color: #000000;\">KS TMA #8 2016: Approx. 3 tumor cores and 16 benign cores from 1 case <span style=\"color: #777777;\">(Limited availability; please inquire)<\/span><\/span> <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Autopsy-KS-TMA-8-2016-HE-stain.png\" target=\"_blank\" rel=\"noopener\">Image<\/a>\u00a0<\/strong><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><img class=\"wp-image-7089 aligncenter\" src=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Autopsy-KS-TMA-4-2016-HE-stain-150x150.png\" alt=\"\" width=\"279\" height=\"279\" \/><\/p>\n\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"iw-so-tabs-panel\" id=\"tab-1-9-content\">\n\t\t\t\t<p class=\"has-medium-font-size\"><span style=\"color: #7777777; font-weight: 500;\"><span style=\"color: #000000;\">Multsite Autopsies (HIV related Lung Cancer) includes involved and uninvolved tissues. Examples of TMA images are provided in the \"Image\" links below. <\/span><strong><span style=\"color: #000000;\">Please go to our <a style=\"color: #000000;\" href=\"http:\/\/www.acsr1.com\/contact\/image-access-form\/\" target=\"_blank\" rel=\"noopener noreferrer\">ACSR Digital Library<\/a>\u00a0for the complete collection of TMA images.<\/span><\/strong><\/span><\/p>\n<ul>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">Autopsy Lung TMA #15 2019: Approx. 5 tumor cores and 10 benign cores from 1 case <strong><span style=\"font-weight: 500;\">(Limited availability; please inquire)<\/span><\/strong><\/span>\u00a0<a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Autopsy-Lung-TMA-15-2019-HE-stain.png\" target=\"_blank\" rel=\"noopener\"><strong>image<\/strong><\/a><\/span><\/li>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">Autopsy Lung TMA #16 2019: Approx. 7 tumor cores and 11 benign cores from 1 case <strong><span style=\"font-weight: 500;\">(Limited availability; please inquire)<\/span><\/strong><\/span> <a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Autopsy-Lung-TMA-16-2019-HE-stain.png\" target=\"_blank\" rel=\"noopener\"><strong>image<\/strong><\/a><\/span><\/li>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">Autopsy Lung TMA #17 2019: Approx. 2 tumor cores and 15 benign cores from 1 case <strong><span style=\"font-weight: 500;\">(Limited availability; please inquire)<\/span><\/strong><\/span> <a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Autopsy-Lung-TMA-17-2019-HE-stain.png\" target=\"_blank\" rel=\"noopener\"><strong>image<\/strong><\/a><\/span><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><img class=\"size-medium wp-image-7171 aligncenter\" src=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/Autopsy-Lung-TMA-17-2019-HE-stain-e1679431379983-289x300.png\" alt=\"\" width=\"289\" height=\"300\" \/><\/p>\n<p>&nbsp;<\/p>\n\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"iw-so-tabs-panel\" id=\"tab-1-10-content\">\n\t\t\t\t<p class=\"has-medium-font-size\"><span style=\"color: #000000;\">A randomized trial conducted from 2007 to 2011 to evaluate the efficacy of a protease inhibitor-based antiretroviral therapy regimen compared with a non-nucleoside reverse transcriptase inhibitor-based regimen to treat HIV-related histologically-confirmed KS in adults in Uganda. Data and biospecimens collected at multiple time points \u00a0from a cohort of &gt;200 participants.\u00a0 Examples of TMA images are provided in the \"Image\" links below.<\/span><strong><span style=\"color: #000000;\"> Please go to our<\/span>\u00a0<a href=\"http:\/\/www.acsr1.com\/contact\/image-access-form\/\" target=\"_blank\" rel=\"noopener noreferrer\">ACSR Digital Library<\/a>\u00a0<span style=\"color: #000000;\">for the complete collection of TMA images.<\/span><\/strong><\/p>\n<p>&nbsp;<\/p>\n<p><img class=\"size-medium wp-image-7177 alignright\" src=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/ARKS-KS-TMA-2-2020-HE-stain-300x261.png\" alt=\"\" width=\"300\" height=\"261\" \/><\/p>\n<ul>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">ARKS TMA 1 2020: Approx. 37 tumor cores from 37 cases<\/span> <a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/ARKS-KS-TMA-1-2020-HE-stain.png\" target=\"_blank\" rel=\"noopener\"><strong>image<\/strong><\/a><\/span><\/li>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">ARKS TMA 2 2020: Approx. 36 tumor cores from 36 cases<\/span> <a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/ARKS-KS-TMA-2-2020-HE-stain.png\" target=\"_blank\" rel=\"noopener\"><strong>image<\/strong><\/a><\/span><\/li>\n<\/ul>\n<ul>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">ARKS TMA 3 2020: Approx. 35 tumor cores from 35 cases<\/span> <a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/ARKS-KS-TMA-3-2020-HE-stain.png\" target=\"_blank\" rel=\"noopener\"><strong>image<\/strong><\/a><\/span><\/li>\n<li><span style=\"color: #777777; font-weight: 500;\"><span style=\"color: #000000;\">ARKS TMA 4 2020: Approx. 36 tumor cores from 36 cases<\/span> <strong><a href=\"https:\/\/acsr1.com\/wp-content\/uploads\/2022\/03\/ARKS-KS-TMA-4-2020-HE-stain.png\" target=\"_blank\" rel=\"noopener\">image<\/a>\u00a0<\/strong><\/span><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\n\t<\/div>\n\n<\/div>\n<\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>TMAs Tissue Microarrays (TMAs) Digital Library KS (HIV related) Lymphoma (HIV related) Lymphoma (HIV negative) Non-AIDS-defining Cancers (HIV related) Melanoma (HIV related) Multsite Autopsies (HIV related NHL) Multsite Autopsies (HIV &#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-fullwidth.php","meta":{"_monsterinsights_skip_tracking":false},"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.10 - aioseo.com -->\n\t<meta name=\"description\" content=\"TMAs Tissue Microarrays (TMAs) Digital Library KS (HIV related) Lymphoma (HIV related) Lymphoma (HIV negative) Non-AIDS-defining Cancers (HIV related) Melanoma (HIV related) Multsite Autopsies (HIV related NHL) Multsite Autopsies (HIV related KS) Multisite Autopsies (HIV related Lung Cancer) Antiretrovirals in Kaposi Sarcoma (KS-ARKS) Investigators requesting access to view Tissue Microarray (TMA) images are required to\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.acsr1.com\/?page_id=7937\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.10\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"AIDS and Cancer Specimen Resource | HIV Malignancy Specimens for Research at No Charge\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"From The AIDS and Cancer Specimen Resource (ACSR) Tissue Microarrays | AIDS and Cancer Specimen Resource\" \/>\n\t\t<meta property=\"og:description\" content=\"TMAs Tissue Microarrays (TMAs) Digital Library KS (HIV related) Lymphoma (HIV related) Lymphoma (HIV negative) Non-AIDS-defining Cancers (HIV related) Melanoma (HIV related) Multsite Autopsies (HIV related NHL) Multsite Autopsies (HIV related KS) Multisite Autopsies (HIV related Lung Cancer) Antiretrovirals in Kaposi Sarcoma (KS-ARKS) Investigators requesting access to view Tissue Microarray (TMA) images are required to\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.acsr1.com\/?page_id=7937\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.acsr1.com\/wp-content\/uploads\/2017\/04\/cropped-cropped-ACSR_Color-Logo128-e1491856853898.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.acsr1.com\/wp-content\/uploads\/2017\/04\/cropped-cropped-ACSR_Color-Logo128-e1491856853898.png\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2023-03-21T21:41:12+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-07-22T03:20:23+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/acsrbiobank\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@ACSRbiobank\" \/>\n\t\t<meta name=\"twitter:title\" content=\"From The AIDS and Cancer Specimen Resource (ACSR) Tissue Microarrays | AIDS and Cancer Specimen Resource\" \/>\n\t\t<meta name=\"twitter:description\" content=\"TMAs Tissue Microarrays (TMAs) Digital Library KS (HIV related) Lymphoma (HIV related) Lymphoma (HIV negative) Non-AIDS-defining Cancers (HIV related) Melanoma (HIV related) Multsite Autopsies (HIV related NHL) Multsite Autopsies (HIV related KS) Multisite Autopsies (HIV related Lung Cancer) Antiretrovirals in Kaposi Sarcoma (KS-ARKS) Investigators requesting access to view Tissue Microarray (TMA) images are required to\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@ACSRbiobank\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.acsr1.com\/wp-content\/uploads\/2017\/04\/cropped-cropped-ACSR_Color-Logo128-e1491856853898.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?page_id=7937#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.acsr1.com#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.acsr1.com\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?page_id=7937#listItem\",\"name\":\"Tissue Microarrays\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?page_id=7937#listItem\",\"position\":2,\"name\":\"Tissue Microarrays\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.acsr1.com#listItem\",\"name\":\"Home\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/#organization\",\"name\":\"AIDS and Cancer Specimen Resource\",\"description\":\"HIV Malignancy Specimens for Research at No Charge\",\"url\":\"https:\\\/\\\/www.acsr1.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.acsr1.com\\\/wp-content\\\/uploads\\\/2017\\\/04\\\/cropped-cropped-ACSR_Color-Logo128-e1491856853898.png\",\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?page_id=7937\\\/#organizationLogo\",\"width\":250,\"height\":182},\"image\":{\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?page_id=7937\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/acsrbiobank\",\"https:\\\/\\\/twitter.com\\\/ACSRbiobank\",\"https:\\\/\\\/www.instagram.com\\\/acsrbiobank\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/aids-and-cancer-specimen-resource\\\/\"]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?page_id=7937#webpage\",\"url\":\"https:\\\/\\\/www.acsr1.com\\\/?page_id=7937\",\"name\":\"From The AIDS and Cancer Specimen Resource (ACSR) Tissue Microarrays | AIDS and Cancer Specimen Resource\",\"description\":\"TMAs Tissue Microarrays (TMAs) Digital Library KS (HIV related) Lymphoma (HIV related) Lymphoma (HIV negative) Non-AIDS-defining Cancers (HIV related) Melanoma (HIV related) Multsite Autopsies (HIV related NHL) Multsite Autopsies (HIV related KS) Multisite Autopsies (HIV related Lung Cancer) Antiretrovirals in Kaposi Sarcoma (KS-ARKS) Investigators requesting access to view Tissue Microarray (TMA) images are required to\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?page_id=7937#breadcrumblist\"},\"datePublished\":\"2023-03-21T14:41:12-07:00\",\"dateModified\":\"2026-07-21T20:20:23-07:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/#website\",\"url\":\"https:\\\/\\\/www.acsr1.com\\\/\",\"name\":\"AIDS and Cancer Specimen Resource\",\"description\":\"HIV Malignancy Specimens for Research at No Charge\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"From The AIDS and Cancer Specimen Resource (ACSR) Tissue Microarrays | AIDS and Cancer Specimen Resource","description":"TMAs Tissue Microarrays (TMAs) Digital Library KS (HIV related) Lymphoma (HIV related) Lymphoma (HIV negative) Non-AIDS-defining Cancers (HIV related) Melanoma (HIV related) Multsite Autopsies (HIV related NHL) Multsite Autopsies (HIV related KS) Multisite Autopsies (HIV related Lung Cancer) Antiretrovirals in Kaposi Sarcoma (KS-ARKS) Investigators requesting access to view Tissue Microarray (TMA) images are required to","canonical_url":"https:\/\/www.acsr1.com\/?page_id=7937","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/www.acsr1.com\/?page_id=7937#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.acsr1.com#listItem","position":1,"name":"Home","item":"https:\/\/www.acsr1.com","nextItem":{"@type":"ListItem","@id":"https:\/\/www.acsr1.com\/?page_id=7937#listItem","name":"Tissue Microarrays"}},{"@type":"ListItem","@id":"https:\/\/www.acsr1.com\/?page_id=7937#listItem","position":2,"name":"Tissue Microarrays","previousItem":{"@type":"ListItem","@id":"https:\/\/www.acsr1.com#listItem","name":"Home"}}]},{"@type":"Organization","@id":"https:\/\/www.acsr1.com\/#organization","name":"AIDS and Cancer Specimen Resource","description":"HIV Malignancy Specimens for Research at No Charge","url":"https:\/\/www.acsr1.com\/","logo":{"@type":"ImageObject","url":"https:\/\/www.acsr1.com\/wp-content\/uploads\/2017\/04\/cropped-cropped-ACSR_Color-Logo128-e1491856853898.png","@id":"https:\/\/www.acsr1.com\/?page_id=7937\/#organizationLogo","width":250,"height":182},"image":{"@id":"https:\/\/www.acsr1.com\/?page_id=7937\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/acsrbiobank","https:\/\/twitter.com\/ACSRbiobank","https:\/\/www.instagram.com\/acsrbiobank\/","https:\/\/www.linkedin.com\/in\/aids-and-cancer-specimen-resource\/"]},{"@type":"WebPage","@id":"https:\/\/www.acsr1.com\/?page_id=7937#webpage","url":"https:\/\/www.acsr1.com\/?page_id=7937","name":"From The AIDS and Cancer Specimen Resource (ACSR) Tissue Microarrays | AIDS and Cancer Specimen Resource","description":"TMAs Tissue Microarrays (TMAs) Digital Library KS (HIV related) Lymphoma (HIV related) Lymphoma (HIV negative) Non-AIDS-defining Cancers (HIV related) Melanoma (HIV related) Multsite Autopsies (HIV related NHL) Multsite Autopsies (HIV related KS) Multisite Autopsies (HIV related Lung Cancer) Antiretrovirals in Kaposi Sarcoma (KS-ARKS) Investigators requesting access to view Tissue Microarray (TMA) images are required to","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/www.acsr1.com\/#website"},"breadcrumb":{"@id":"https:\/\/www.acsr1.com\/?page_id=7937#breadcrumblist"},"datePublished":"2023-03-21T14:41:12-07:00","dateModified":"2026-07-21T20:20:23-07:00"},{"@type":"WebSite","@id":"https:\/\/www.acsr1.com\/#website","url":"https:\/\/www.acsr1.com\/","name":"AIDS and Cancer Specimen Resource","description":"HIV Malignancy Specimens for Research at No Charge","inLanguage":"en-US","publisher":{"@id":"https:\/\/www.acsr1.com\/#organization"}}]},"og:locale":"en_US","og:site_name":"AIDS and Cancer Specimen Resource | HIV Malignancy Specimens for Research at No Charge","og:type":"article","og:title":"From The AIDS and Cancer Specimen Resource (ACSR) Tissue Microarrays | AIDS and Cancer Specimen Resource","og:description":"TMAs Tissue Microarrays (TMAs) Digital Library KS (HIV related) Lymphoma (HIV related) Lymphoma (HIV negative) Non-AIDS-defining Cancers (HIV related) Melanoma (HIV related) Multsite Autopsies (HIV related NHL) Multsite Autopsies (HIV related KS) Multisite Autopsies (HIV related Lung Cancer) Antiretrovirals in Kaposi Sarcoma (KS-ARKS) Investigators requesting access to view Tissue Microarray (TMA) images are required to","og:url":"https:\/\/www.acsr1.com\/?page_id=7937","og:image":"https:\/\/www.acsr1.com\/wp-content\/uploads\/2017\/04\/cropped-cropped-ACSR_Color-Logo128-e1491856853898.png","og:image:secure_url":"https:\/\/www.acsr1.com\/wp-content\/uploads\/2017\/04\/cropped-cropped-ACSR_Color-Logo128-e1491856853898.png","article:published_time":"2023-03-21T21:41:12+00:00","article:modified_time":"2026-07-22T03:20:23+00:00","article:publisher":"https:\/\/www.facebook.com\/acsrbiobank","twitter:card":"summary","twitter:site":"@ACSRbiobank","twitter:title":"From The AIDS and Cancer Specimen Resource (ACSR) Tissue Microarrays | AIDS and Cancer Specimen Resource","twitter:description":"TMAs Tissue Microarrays (TMAs) Digital Library KS (HIV related) Lymphoma (HIV related) Lymphoma (HIV negative) Non-AIDS-defining Cancers (HIV related) Melanoma (HIV related) Multsite Autopsies (HIV related NHL) Multsite Autopsies (HIV related KS) Multisite Autopsies (HIV related Lung Cancer) Antiretrovirals in Kaposi Sarcoma (KS-ARKS) Investigators requesting access to view Tissue Microarray (TMA) images are required to","twitter:creator":"@ACSRbiobank","twitter:image":"https:\/\/www.acsr1.com\/wp-content\/uploads\/2017\/04\/cropped-cropped-ACSR_Color-Logo128-e1491856853898.png"},"aioseo_meta_data":{"post_id":"7937","title":"From The AIDS and Cancer Specimen Resource (ACSR) #post_title | #site_title","description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":{"id":"#aioseo-web-page-65cab78267cc5","slug":"web-page","graphName":"WebPage","label":"Web Page","properties":{"type":"WebPage","name":"","description":""}}},"graphName":"WebPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":"{\"article\":{\"articleType\":\"BlogPosting\"},\"course\":{\"name\":\"\",\"description\":\"\",\"provider\":\"\"},\"faq\":{\"pages\":[]},\"product\":{\"reviews\":[]},\"recipe\":{\"ingredients\":[],\"instructions\":[],\"keywords\":[]},\"software\":{\"reviews\":[],\"operatingSystems\":[]},\"webPage\":{\"webPageType\":\"WebPage\"},\"blockGraphs\":[]}","pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":{"faqs":[],"keyPoints":[],"schemas":[],"titles":[],"descriptions":[],"socialPosts":{"email":{"subject":"","preview":"","content":""},"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2023-03-21 15:43:55","updated":"2026-07-22 04:23:48","seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.acsr1.com\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tTissue Microarrays\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.acsr1.com"},{"label":"Tissue Microarrays","link":"https:\/\/www.acsr1.com\/?page_id=7937"}],"_links":{"self":[{"href":"https:\/\/www.acsr1.com\/index.php?rest_route=\/wp\/v2\/pages\/7937"}],"collection":[{"href":"https:\/\/www.acsr1.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.acsr1.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.acsr1.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.acsr1.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7937"}],"version-history":[{"count":407,"href":"https:\/\/www.acsr1.com\/index.php?rest_route=\/wp\/v2\/pages\/7937\/revisions"}],"predecessor-version":[{"id":9657,"href":"https:\/\/www.acsr1.com\/index.php?rest_route=\/wp\/v2\/pages\/7937\/revisions\/9657"}],"wp:attachment":[{"href":"https:\/\/www.acsr1.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7937"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}